- €1.75bn
- €2.03bn
- €952.17m
Brief: Fagron H1 Group REBIDTA up 14% at EUR 72.2 Mln
Brief: Fagron H1 EPS at EUR 0.46
Brief: Fagron Increases Share Capital Through Rights Issue
Fagron jumps on solid Q1 revenue
Brief: Fagron Q1 Revenue Up At Eur 181.4 Mln
Fagron's FY beat puts shares on track for best day in 5 yrs
Brief: Fagron Reports FY Revenue Growth of 10.3%
Fagron slumps to almost 5-yr lows after U.S. site sales outlook cut
Brief: Fagron Q3 Revenue Up At EUR 173 Million
Brief: Fagron H1 EPS Up 29.7% At EUR 0.48
Brief: Fagron Buys 503B Outsourcing Facility In Boston
Fagron extends losses after FDA warning on U.S. plant
Brief: Fagron: FDA Updates Warning Letter About Minnesota Facility
French and Benelux stocks-Factors to watch
Brief: Fagron Increases Share Capital Through Exercise Subscription Rights
Brief: Fagron Q1 Turnover Up At 156.4 Million Euros
Brief: Fagron Sees 8% Organic Revenue CAGR For Period Until 2026
Brief: Fagron FY REBITDA Down At 118.3 Million Euros
Earnings Poll: Fagron NV full year results due on February 10